Zealand, Boehringer receive FDA breakthrough status for treatment of fatty liver dystrophy
Danish Zealand Pharma and German partner Boehringer Ingelheim have won the US Food and Drug Administration’s Breakthrough Therapy competition to review their experimental weight-loss drug for the treatment of fatty liver disease.
BELIEBTE BEITRÄGE
Kenya moves 50 elephants to larger reserve
Oktober 16, 2024
Germany to provide $3 billion in decarbonisation subsidies
Oktober 16, 2024
Australia’s Meteobureau says the likelihood of La Niña is decreasing
Oktober 16, 2024
Apple TV+ launches ‘Silo’ season 2 trailer
Oktober 16, 2024
LIVEÜBERTRAGUNG